tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN

Compare Newron Pharmaceuticals SpA (NWRN) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
CHF27.85
CHF608.44M
23.25
202.06%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.37
CHF136.47M
-2.01
-32.78%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF55.40
CHF674.83M
9.05
31.31%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.74
CHF922.59M
-5.60
418.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF13.88
CHF194.64M
-2.71
12.66%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF25.70
CHF148.23M
4.70
-3.80%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:NWRN
Newron Pharmaceuticals SpA
27.85
18.94
212.57%
CH:MOLN
Molecular Partners AG
3.26
-1.74
-34.80%
CH:BSLN
Basilea Pharmaceutica
54.10
13.45
33.09%
CH:IDIA
Idorsia Ltd
3.75
3.00
405.40%
CH:SANN
Santhera Pharmaceuticals Holding
13.88
0.64
4.83%
CH:XLS
Xlife Sciences Ltd.
25.30
0.30
1.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts